HomeNewsTrendsMSME associations in Maharashtra oppose lockdown, seek clarity on units that can operate

MSME associations in Maharashtra oppose lockdown, seek clarity on units that can operate

According to the MSME Ministry’s FY21 annual report there are about 47.78 lakh MSMEs in Maharashtra as per the National Sample Survey 73rd Round (2015-2016) of which 47.60 micro and 17,000 medium enterprises respectively.

April 15, 2021 / 15:42 IST
Story continues below Advertisement
Several associations like TIA have demanded clarity on the industries which can work with limited workforce. [Representative Image: Reuters]
Several associations like TIA have demanded clarity on the industries which can work with limited workforce. [Representative Image: Reuters]

As Maharashtra undergoes a two week lockdown starting today, MSME associations in the state have opposed the government's lockdown restrictions fearing that it would push recovery to pre COVID-19 levels further and make revival difficult.

"Businesses have not recovered from the first lockdown yet, and now another has been announced. If this is how it continues I do not know how the businesses will even survive," said Satish Shetty, President, Taloja Industries Association (TIA)

Story continues below Advertisement

"As per the authorities’ orders, we have been conducting routine RT PCR tests for all workers. Why did they make us follow SOPs and spend so much on tests when they anyway announced a lockdown," argued Shetty.

"First six months of 2020 were disrupted as a majority of labour had gone back to their hometown and very few had returned. The labour has again started moving back, I don't know how many will return to work now. We understand the government's limitations but they should also understand our situation and allow us to work with at least some manpower. MSMEs have been the worst hit because of COVID-19," Shetty added.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show